Skip to main content

Table 3 Demographic characteristics of the sample

From: Head to head randomized trial of two decision aids for prostate cancer

 

Biopsy survey

Pre-encounter survey

Post-encounter survey

N (%)

N (%)

N (%)

Simple decision aid

Complex decision aid

Simple decision aid

Complex decision aid

Simple decision aid

Complex decision aid

N = 510

N = 512

N = 141

N = 144

N = 122

N = 122

Age

 M (SD)

63.41 (5.86)

63.14 (6.02)

63.35 (5.99)

63.13 (6.22)

64.01 (5.78)

63.02 (6.06)

Race and ethnicity

 Caucasian

385 (75.6)

397 (77.5)

99 (70.2)

105 (72.9)

91 (74.6)

89 (73.0)

 African American

115 (22.6)

106 (20.7)

39 (27.7)

36 (25.0)

29 (23.8)

29 (23.8)

 American Indian or Alaskan Native

15 (2.9)

14 (2.7)

5 (3.5)

3 (2.1)

3 (2.5)

2 (1.6)

 Pacific Islander or Native Hawaiian`

0 (0.0)

1 (0.2)

0 (0.0)

1 (0.7)

0 (0.0)

1 (0.8)

 Asian

1 (0.2)

6 (1.2)

0 (0.0)

2 (1.4)

0 (0.0)

2 (1.6)

 Hispanic

11 (2.2)

11 (2.1)

2 (1.4)

3 (2.1)

2 (1.6)

3 (2.5)

 Middle Eastern

2 (0.4)

2 (0.4)

0 (0.0)

1 (0.7)

0 (0.0)

1 (0.8)

Education

  < High school

27 (5.3)

23 (4.5)

3 (2.1)

3 (2.1)

3 (2.5)

1 (0.8)

 High school/GED

144 (28.4)

161 (31.5)

40 (28.4)

41 (28.5)

37 (30.3)

32 (26.2)

 Trade school

21 (4.1)

25 (4.9)

4 (2.8)

8 (5.6)

4 (3.3)

7 (5.7)

 Some college/Assoc

223 (44)

210 (41.1)

66 (46.9)

63 (43.8)

56 (45.9)

57 (46.7)

 College degree

92 (18.1)

92 (18)

28 (19.9)

29 (20.2)

22 (18)

25 (20.5)

Marital status

 Married/partner

280 (55.2)

285 (55.9)

72 (51.4)

83 (57.6)

60 (49.6)

70 (57.4)

 Divorced/separated

162 (32)

166 (32.6)

51 (36.5)

49 (34)

46 (38)

39 (31.9)

 Widowed

27 (5.3)

18 (3.5)

4 (2.9)

4 (2.8)

3 (2.5)

4 (3.3)

 Never married

38 (7.5)

41 (8.0)

13 (9.3)

8 (5.6)

12 (9.9)

9 (7.4)

Literacy

 Inadequate

140 (27.7)

139 (27.4)

34 (24.3)

41 (28.9)

30 (24.8)

32 (26.7)

 Adequate

366 (72.3)

368 (72.6)

106 (75.7)

101 (71.1)

91 (75.2)

88 (73.3)

Numeracy

 M (SD)

4.57 (1.03)

4.56 (1.01)

4.69 (0.96)

4.69 (0.85)

4.64 (0.97)

4.75 (0.83)

Gleason score

 Gleason 6

72 (14.1)

72 (14.1)

72 (51.1)

72 (50.0)

59 (50.9)

54 (47.0)

 Gleason 7

69 (13.5)

72 (14.1)

69 (48.9)

72 (50.0)

57 (49.1)

61 (53.0)

PSA

 M (SD)

5.98 (2.98)

6.12 (2.61)

5.98 (2.98)

6.12 (2.61)

6.25 (3.13)

6.07 (2.68)

  1. Demographics for biopsy interview are all patients recruited into the study (text only includes patients ultimately diagnosed with cancer). PSA and Gleason scores were only extracted from electronic medical records for patients diagnosed with localized cancer